Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: A systematic review and meta-analysis

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Tolkien, Zoe ^a,d   Stecher, Lynne ^b,c   Mander, Adrian P ^b   Pereira, Dora I A ^a   Powell, Jonathan J ^a  

^a MRC HUMAN NUTRITION RESEARCH   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FERROUS SULFATE; IRON; PLACEBO; FERROUS ION;

ABDOMINAL PAIN; ABNORMAL FECES; ADULT; CONSTIPATION; DIARRHEA; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; GASTROINTESTINAL SYMPTOM; HEARTBURN; HUMAN; IRON THERAPY; META ANALYSIS; NAUSEA; PREGNANCY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VOMITING; ADVERSE EFFECTS; ANEMIA, IRON-DEFICIENCY; CLINICAL TRIAL (TOPIC); DIETARY SUPPLEMENT; FACTUAL DATABASE; GASTROINTESTINAL DISEASES; ODDS RATIO; PLACEBO EFFECT;

ANEMIA, IRON-DEFICIENCY; CLINICAL TRIALS AS TOPIC; DATABASES, FACTUAL; DIETARY SUPPLEMENTS; FERROUS COMPOUNDS; GASTROINTESTINAL DISEASES; HUMANS; ODDS RATIO; PLACEBO EFFECT;

EID: 84923699055     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0117383     Document Type: Review

References (91)

1. WHO (2008) Global database on anaemia. Available: http://who.int/vmnis/anaemia/data/database/ countries/en/
2. Adamson EA, Bailey GR, Richards N, Wilson H (2008) Prevalence of anaemia in an inner city primary school population. Arch Dis Child 93: 453. doi: 10.1136/adc.2007.116301 PMID: 18426951
3. Hercberg S, Preziosi P, Galan P (2001) Iron deficiency in Europe. Public Health Nutr 4: 537-545. PMID: 11683548
4. Pavord S, Myers B, Robinson S, Allard S, Strong J, et al. (2012) UK guidelines on the management of iron deficiency in pregnancy. Br J Haematol 156: 588-600. PMID: 22512001
5. Abdullah K, Kendzerska T, Shah P, Uleryk E, Parkin PC (2012) Efficacy of oral iron therapy in improving the developmental outcome of pre-school children with non-anaemic iron deficiency: a systematic review. Public Health Nutr: 1-10.
6. Pasricha SRS, De-Regil LM (2012) Daily iron supplementation for improving iron status and health among menstruating women (Protocol). Cochrane Database of Syst Rev 4: CD009747.
7. Gasche C, Lomer MC, Cavill I, Weiss G (2004) Iron, anaemia, and inflammatory bowel diseases. Gut 53: 1190-1197. PMID: 15247190
8. Gasche C, Berstad A, Befrits R, Beglinger C, Dignass A, et al. (2007) Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis 13: 1545-1553. PMID: 17985376
9. Cook JD (2005) Diagnosis and management of iron-deficiency anaemia. Best Pract Res Clin Haematol 18: 319-332. PMID: 15737893
10. NHS (2012) GP prescribing data. Available: http://www.hscic.gov.uk/gpprescribingdata
11. Cancelo-Hidalgo MJ, Castelo-Branco C, Palacios S, Haya-Palazuelos J, Ciria-Recasens M, et al. (2013) Tolerability of different oral iron supplements: a systematic review. Curr Med Res Opin 29: 291-303. doi: 10.1185/03007995.2012.761599 PMID: 23252877
12. Ojukwu JU, Okebe JU, Yahav D, Paul M (2009) Oral iron supplementation for preventing or treating anaemia among children in malaria-endemic areas. Cochrane Database Syst Rev 3: CD006589. doi: 10.1002/14651858.CD006589.pub2 PMID: 19588399
13. Okebe JU, Yahav D, Shbita R, Paul M (2011) Oral iron supplements for children in malaria-endemic areas. Cochrane Database Syst Rev 10: CD006589. doi: 10.1002/14651858.CD006589.pub3 PMID: 21975754
14. Pena-Rosas JP, De-Regil LM, Dowswell T, Viteri FE (2012) Daily oral iron supplementation during pregnancy. Cochrane Database Syst Rev 12: CD004736. doi: 10.1002/14651858.CD004736.pub4 PMID: 23235616
15. Pena-Rosas JP, De-Regil LM, Dowswell T, Viteri FE (2012) Intermittent oral iron supplementation during pregnancy. Cochrane Database Syst Rev 7: CD009997. doi: 10.1002/14651858.CD009997 PMID: 22786531
16. Hallberg L, Ryttinger L, Solvell L (1966) Side-effects of oral iron therapy. A double-blind study of different iron compounds in tablet form. Acta Med Scand Suppl 459: 3-10. PMID: 5957969
17. Kortman GA, Boleij A, Swinkels DW, Tjalsma H (2012) Iron availability increases the pathogenic potential of Salmonella typhimurium and other enteric pathogens at the intestinal epithelial interface. PLoS One 7: e29968. doi: 10.1371/journal.pone.0029968 PMID: 22272265
18. Werner T, Wagner SJ, Martinez I, Walter J, Chang JS, et al. (2011) Depletion of luminal iron alters the gut microbiota and prevents Crohn's disease-like ileitis. Gut 60: 325-333. doi: 10.1136/gut.2010. 216929 PMID: 21076126
19. Zimmermann MB, Chassard C, Rohner F, N'Goran E K, Nindjin C, et al. (2010) The effects of iron fortification on the gut microbiota in African children: a randomized controlled trial in Cote d'Ivoire. Am J Clin Nutr 92: 1406-1415. doi: 10.3945/ajcn.110.004564 PMID: 20962160
20. Radulescu S, Brookes MJ, Salgueiro P, Ridgway RA, McGhee E, et al. (2012) Luminal iron levels govern intestinal tumorigenesis after apc loss in vivo. Cell Rep 2: 270-282. doi: 10.1016/j.celrep.2012.07. 003 PMID: 22884366
21. Ahn E, Pairaudeau N, Cerat Y, Couturier B, Fortier A, et al. (2006) A randomized cross over trial of tolerability and compliance of a micronutrient supplement with low iron separated from calcium vs high iron combined with calcium in pregnant women [ISRCTN56071145]. BMC Pregnancy and Childbirth 6. PMID: 17190589
22. Coplin M, Schuette S, Leichtmann G, Lashner B (1991) Tolerability of iron: a comparison of bis-glycino iron II and ferrous sulfate. Clinical Therapeutics 13: 606-612. PMID: 1799918
23. Habib F, Habib Zein Alabdin E, Alenazy M, Nooh R (2009) Compliance to iron supplementation during pregnancy. Journal of Obstetrics and Gynaecology 29: 487-492. doi: 10.1080/01443610902984961 PMID: 19697194
24. Hallberg L, Ryttinger L, Solvell L (1966) Side-effects of oral iron therapy. A double-blind study of different iron compounds in tablet form. Acta medica Scandinavica Supplementum 180: 3-10.
25. Langstaff R, Geisser P, Heil W, Bowdler J (1993) Treatment of iron-deficiency anaemia: A lower incidence of adverse effects with Ferrum Hausmann than ferrous sulphate. Br J Clin Res 4: 191-198.
26. Saha L, Pandhi P, Gopalan S, Malhotra S, Saha PK (2007) Comparison of efficacy, tolerability, and cost of iron polymaltose complex with ferrous sulphate in the treatment of iron deficiency anemia in pregnant women. MedGenMed 9: 1. PMID: 18311352
27. Souza AI, Batista Filho M, Bresani CC, Ferreira LOC, Figueiroa JN (2009) Adherence and side effects of three ferrous sulfate treatment regimens on anemic pregnant women in clinical trials. Cad Saude Publica 25: 1225-1233. PMID: 19503953
28. Zaim M, Piselli L, Fioravant iP, Kanony-Truc C(2011) Efficacy and tolerability of a prolonged release ferrous sulphate formulation in iron deficiency anaemia: a non-inferiority controlled trial. Eur J Nutr 51: 221-229. doi: 10.1007/s00394-011-0210-7 PMID: 21643774
29. Lindgren S, Wikman O, Befrits R, Blom H, Eriksson A, et al. (2009) Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study. Scandinavian Journal of Gastroenterology 44: 838-845. doi: 10.1080/00365520902839667 PMID: 19330567
30. Lindgren S, Wikman O, Befrits R, Blom H, Eriksson A, et al. (2009) Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study. Scand J Gastroenterol 44: 838-845. doi: 10.1080/ 00365520902839667 PMID: 19330567
31. Santiago P (2012) Ferrous versus ferric oral iron formulations for the treatment of iron deficiency: a clinical overview. Scientific World Journal 2012: 846824. doi: 10.1100/2012/846824 PMID: 22654638
32. Gasche C, Evstatiev R, Haas T, Kaser A, Knoflach P, et al. (2011) [Diagnosis and treatment of iron deficiency and anaemia in inflammatory bowel diseases. Consensus of the Austrian IBD Working Party]. Z Gastroenterol 49: 627-632. doi: 10.1055/s-0031-1273324 PMID: 21526463
33. Stein J, Hartmann F, Dignass AU (2010) Diagnosis and management of iron deficiency anemia in patients with IBD. Nat Rev Gastroenterol Hepatol 7: 599-610. doi: 10.1038/nrgastro.2010.151 PMID: 20924367
34. Mirrezaie SM, Parsi R, Torabgahromi SA, Askarian M (2008) Low dose, short-term iron supplementation in female blood donors of childbearing age: A randomized, double-masked, placebo-controlled study. Iranian Journal of Medical Sciences 33: 138-143.
35. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Controlled Clinical Trials 7: 177-188. PMID: 3802833
36. Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, et al. (2011) The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 343: d5928. doi: 10.1136/bmj.d5928 PMID: 22008217
37. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560. PMID: 12958120
38. Elbourne DR, Altman DG, Higgins JP, Curtin F, Worthington HV, et al. (2002) Meta-analyses involving cross-over trials: methodological issues. Int J Epidemiol 31: 140-149. PMID: 11914310
39. Pieracci F, Henderson P, Rodney J, Holena D, Genisca A, et al. (2009) Randomized, double-blind, pla-cebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness. Surgical infections 10: 9-19.
40. Pereira D, Couto Irving SS, Lomer MC, Powell JJ (2014) A rapid, simple questionnaire to assess gastrointestinal symptoms after oral ferrous sulphate supplementation. BMC Gastroenterol 14: 103. doi: 10.1186/1471-230X-14-103 PMID: 24899360
41. Sutton PM, Cresswell T, Livesey JP, Speed K, Bagga T (2004) Treatment of anaemia after joint replacement. A double-blind, randomised, controlled trial of ferrous sulphate versus placebo. J Bone Joint Surg Br 86: 31-33. PMID: 14765861
42. WHO (2008) The global burden of disease: 2004 update. Geneva: WHO. 1-146 p. PMID: 25506952
43. Saha L, Pandhi P, Gopalan S, Malhotra S, Saha P (2007) Comparison of efficacy, tolerability, and cost of iron polymaltose complex with ferrous sulphate in the treatment of iron deficiency anemia in pregnant women. MedGenMed: Medscape general medicine 9: 1. PMID: 18311352
44. Carrier J, Aghdassi E, Cullen J, Allard JP (2002) Iron supplementation increases disease activity and vitamin E ameliorates the effect in rats with dextran sulfate sodium-induced colitis. J Nutr 132: 3146-3150. PMID: 12368409
45. Lund EK, Wharf SG, Fairweather-Tait SJ, Johnson IT (1999) Oral ferrous sulfate supplements increase the free radical-generating capacity of feces from healthy volunteers. Am J Clin Nutr 69: 250-255. PMID: 9989688
46. Orozco MN, Solomons NW, Schumann K, Friel JK, de Montenegro AL (2010) Antioxidant-rich oral supplements attenuate the effects of oral iron on in situ oxidation susceptibility of human feces. J Nutr 140: 1105-1110. doi: 10.3945/jn.109.111104 PMID: 20392879
47. Dostal A, Chassard C, Hilty FM, Zimmermann MB, Jaeggi T, et al. (2012) Iron depletion and repletion with ferrous sulfate or electrolytic iron modifies the composition and metabolic activity of the gut microbiota in rats. J Nutr 142: 271-277. doi: 10.3945/jn.111.148643 PMID: 22190022
48. Koloski NA, Talley NJ, Boyce PM (2003) Does psychological distress modulate functional gastrointestinal symptoms and health care seeking? A prospective, community Cohort study. Am J Gastroenterol 98: 789-797. PMID: 12738457
49. Sobieraj DM, Coleman SM, Coleman CI (2011) US prevalence of upper gastrointestinal symptoms: a systematic literature review. Am J Manag Care 17: e449-458. PMID: 22200062
50. Heading RC (1999) Prevalence of upper gastrointestinal symptoms in the general population: a systematic review. Scand J Gastroenterol Suppl 231: 3-8. PMID: 10565617
51. Portincasa P, Maggipinto A, Berardino M, Bonfrate L, Costin S, et al. (2009) Assessing gastrointestinal symptoms and perception, quality of life, motility, and autonomic neuropathy in clinical studies. J Gastrointestin Liver Dis 18: 205-211. PMID: 19565052
52. Rimon E, Kagansky N, Kagansky M, Mechnick L, Mashiah T, et al. (2005) Are we giving too much iron? Low-dose iron therapy is effective in octogenarians. Am J Med 118: 1142-1147. PMID: 16194646
53. Roth JL, Pugh LC (1998) Side effects of alternative iron supplementation: a pilot study. Pa Nurse 53: 16-18. PMID: 10614442
54. Liguori L (1993) Iron protein succinylate in the treatment of iron deficiency: controlled, double-blind, multicenter clinical trial on over 1,000 patients. Int J Clin Pharmacol Ther Toxicol 31: 103-123. PMID: 8468108
55. McDiarmid T, Johnson ED (2002) Clinical inquiries. Are any oral iron formulations better tolerated than ferrous sulfate? J Fam Pract 51: 576. PMID: 12100787
56. Bayoumeu F, Subiran-Buisset C, Baka NE, Legagneur H, Monnier-Barbarino P, et al. (2002) Iron therapy in iron deficiency anemia in pregnancy: Intravenous route versus oral route. American Journal of Obstetrics and Gynecology 186: 518-522. PMID: 11904617
57. Bencaiova G, von Mandach U, Zimmermann R (2009) Iron prophylaxis in pregnancy: Intravenous route versus oral route. European Journal of Obstetrics Gynecology and Reproductive Biology 144: 135-139. doi: 10.1016/j.ejogrb.2009.03.006 PMID: 19406557
58. Strickland ID, Chaput de Saintonge DM, Boulton FE, Francis B, Roubikova J, et al. (1977) The therapeutic equivalence of oral and intravenous iron in renal dialysis patients. Clin Nephrol 7: 55-57. PMID: 321170
59. Waldvogel S, Pedrazzini B, Vaucher P, Bize R, Cornuz J, et al. (2012) Clinical evaluation of iron treatment efficiency among non-anemic but iron-deficient female blood donors: a randomized controlled trial. BMC Med 10: 8. doi: 10.1186/1741-7015-10-8 PMID: 22272750
60. Vaucher P, Druais PL, Waldvogel S, Favrat B (2012) Effect of iron supplementation on fatigue in nonanemic menstruating women with low ferritin: a randomized controlled trial. CMAJ 184: 1247-1254. doi: 10.1503/cmaj.110950 PMID: 22777991
61. Guerra Merino S, López Picado A, Muñoz Hernández H, Marín Mesa JM, Lete Lasa I, et al. (2012) Randomized clinical trial to evaluate the effectiveness of two routes of iron administration, oral and intravenous, in the treatment of postpartum iron deficiency anemia. Ensayo clínico aleatorizado para evaluar la efectividad de dos vías de administración de hierro, oral e intravenosa, en el tratamiento de la anemia ferropénica posparto 39: 190-195.
62. Baykan A, Yalcin SS, Yurdakok K (2006) Does maternal iron supplementation during the lactation period affect iron status of exclusively breast-fed infants? Turkish Journal of Pediatrics 48: 301-307. PMID: 17290563
63. Cook J, Carriaga M, Kahn S, Schalch W, Skikne B (1990) Gastric delivery system for iron supplementation. Lancet 335: 1136-1139. PMID: 1971872
64. Davis BJ, Rajput A, Rajput ML, Aul EA, Eichhorn GR (2000) A randomized, double-blind placebo-controlled trial of iron in restless legs syndrome. European Neurology 43: 70-75. PMID: 10686463
65. Fouad GT, Evans M, Sharma P, Baisley J, Crowley D, et al. (2013) A randomized, double-blind clinical study on the safety and tolerability of an iron multi-amino acid chelate preparation in premenopausal women. J Diet Suppl 10: 17-28. doi: 10.3109/19390211.2012.758217 PMID: 23387416
66. Ganzoni AM, Toendury G, Rhyner K (1974) Oral iron therapy: tolerance for iron sulfate and iron sulfate + succinic acid, and influence on hemoglobin concentration of healthy subjects. ORALE EISENMEDIKATION. VERTRAGLICHKEIT VON EISENSULFAT UND EISENSULFAT + BERNSTEINSAURE, EINFLUSS AUF DIE HAMOGLOBINKONZENTRATION GESUNDER. Dtsch Med Wochenschr (Deutsche Medizinische Wochenschrift) 99: 1175-1178. PMID: 4600156
67. Gordeuk VR, Brittenham GM, Hughes MA, Keating LJ (1987) Carbonyl iron for short-term supplementation in female blood donors. Transfusion 27: 80-85. PMID: 3810831
68. Levy F, Andersen P, Ekren T (1978) Absorption and side-effects after peroral administration of sustained release iron tablets. Ferro-Retard Compared with Ferronicum and Duroferon Duretter. Acta Medica Scandinavica 204: 303-310. PMID: 358765
69. Maghsudlu M, Nasizadeh S, Toogeh G, Zandieh T, Parandoush S, et al. (2008) Short-term ferrous sulfate supplementation in female blood donors. Transfusion 48: 1192-1197. doi: 10.1111/j.1537-2995. 2007.01671.x PMID: 18363581
70. Meier PR, Nickerson HJ, Olson KA, Berg RL, Meyer JA (2003) Prevention of iron deficiency anemia in adolescent and adult pregnancies. Clin Med Res 1: 29-36. PMID: 15931282
71. Makrides M, Crowther C, Gibson R, Gibson R, Skeaff C (2003) Efficacy and tolerability of low-dose iron supplements during pregnancy: a randomized controlled trial. The American journal of clinical nutrition 78: 145-153. PMID: 12816784
72. Tuomainen T-P, Nyyssonen K, Porkkala-Sarataho E, Salonen R, Baumgartner J, et al. (1999) Oral supplementation with ferrous sulfate but not with nonionic iron polymaltose complex increases the susceptibility of plasma lipoproteins to oxidation. Nutrition Research 19: 1121-1132.
73. Yalcin SS, Baykan A, Yurdakok K, Yalcin S, Gucus AI (2009) The factors that affect milk-to-serum ratio for iron during early lactation. J Pediatr Hematol Oncol (Journal of Pediatric Hematology/Oncology) 31: 85-90. doi: 10.1097/MPH.0b013e31819146c2 PMID: 19194189
74. Agarwal R, Rizkala AR, Bastani B, Kaskas MO, Leehey DJ, et al. (2006) A randomized controlled trial of oral versus intravenous iron in chronic kidney disease. American Journal of Nephrology 26: 445-454. PMID: 17035697
75. Auerbach M, Ballard H, Trout JR, McIlwain M, Ackerman A, et al. (2004) Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial. J Clin Oncol 22: 1301-1307. PMID: 15051778
76. Bhandal N, Russell R (2006) Intravenous versus oral iron therapy for postpartum anaemia. BJOG: An International Journal of Obstetrics and Gynaecology 113: 1248-1252. PMID: 17004982
77. Breymann C, Gliga F, Bejenariu C, Strizhova N (2008) Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia. Int J Gynaecol Obstet 101: 67-73. doi: 10.1016/j.ijgo.2007.10.009 PMID: 18234203
78. Charytan C, Qunibi W, Bailie GR (2005) Comparison of intravenous iron sucrose to oral iron in the treatment of anemic patients with chronic kidney disease not on dialysis. Nephron-Clinical Practice 100: c55-c62. doi: 10.1016/j.coph.2014.12.012 PMID: 25614182
79. Henry DH, Dahl NV, Auerbach M, Tchekmedyian S, Laufmane LR (2007) Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy. Oncologist 12: 231-242. PMID: 17296819
80. Mudge DW, Tan KS, Miles R, Johnson DW, Badve SV, et al. (2012) A randomized controlled trial of intravenous or oral iron for posttransplant anemia in kidney transplantation. Transplantation 93: 822-826. doi: 10.1097/TP.0b013e318248375a PMID: 22290270
81. Seid M, Derman R, Baker J, Banach W, Goldberg C, et al. (2008) Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial. American journal of obstetrics and gynecology 199: 435 e431-435 e437.
82. Tokars ML (2010) Comparison of Safety and Efficacy of Intravenous Iron Versus Oral Iron in Chronic Renal Failure Subjects With Anemia. http://clinicaltrials.gov/ct2/show/results/NCT00236977
83. Van Wyck D, Roppolo M, Martinez C, Mazey R, McMurray S (2005) A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD. Kidney international 68: 2846-2856. PMID: 16316362
84. Van Wyck D, Martens M, Seid M, Baker J, Mangione A (2007) Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial. Obstetrics and gynecology 110: 267-278. PMID: 17666600
85. Van Wyck D, Mangione A, Morrison J, Hadley P, Jehle J, et al. (2009) Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial. Transfusion 49: 2719-2728. doi: 10.1111/j.1537-2995.2009.02327.x PMID: 19682342
86. Kochhar PK, Kaundal A, Ghosh P (2013) Intravenous iron sucrose versus oral iron in treatment of iron deficiency anemia in pregnancy: a randomized clinical trial. J Obstet Gynaecol Res 39: 504-510. doi: 10.1111/j.1447-0756.2012.01982.x PMID: 22925176
87. Vazquez Pacheco J (1980) A comparative study of i.v. iron dextran and an oral combination of ferrous sulfate, cyanocobalamin and folic acid in obstetrical patients. Investigacion Medica International 7: 129-135.
88. al-Momen AK, al-Meshari A, al-Nuaim L, Saddique A, Abotalib Z, et al. (1996) Intravenous iron sucrose complex in the treatment of iron deficiency anemia during pregnancy. European journal of obstetrics, gynecology, and reproductive biology 69: 121-124. PMID: 8902444
89. Kulnigg S, Stoinov S, Simanenkov V, Dudar LV, Karnafel W, et al. (2008) A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: The ferric carboxymaltose (FERINJECT) randomized controlled trial. American Journal of Gastroenterology 103: 1182-1192. doi: 10. 1111/j.1572-0241.2007.01744.x PMID: 18371137
90. Reinisch W, Staun M, Tandon RK, Altorjay I, Thillainayagam AV, et al. (2013) A randomized, openlabel, non-inferiority study of intravenous iron isomaltoside 1,000 (monofer) compared with oral iron for treatment of anemia in ibd (proceed). American Journal of Gastroenterology 108: 1877-1888. doi: 10. 1038/ajg.2013.335 PMID: 24145678
91. Schroder O, Mickisch O, Mickisch O Fau-Seidler U, Seidler U Fau-de Weerth A, de Weerth A Fau-Dignass AU, et al. (2005) Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease-a randomized, controlled, open-label, multicenter study. Am J Gastroenterol 100: 2503-2509. PMID: 16279906